MANDATO, Claudia
 Distribuzione geografica
Continente #
AS - Asia 4.569
NA - Nord America 3.498
EU - Europa 1.209
SA - Sud America 443
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 9.759
Nazione #
US - Stati Uniti d'America 3.427
HK - Hong Kong 2.850
SG - Singapore 875
BR - Brasile 368
CN - Cina 366
IT - Italia 352
RU - Federazione Russa 238
VN - Vietnam 206
UA - Ucraina 161
IE - Irlanda 105
DE - Germania 103
TR - Turchia 53
KR - Corea 52
FI - Finlandia 44
SE - Svezia 44
GB - Regno Unito 41
IL - Israele 41
IN - India 37
MX - Messico 31
CA - Canada 30
AT - Austria 29
AR - Argentina 26
NL - Olanda 23
BD - Bangladesh 18
PL - Polonia 17
EC - Ecuador 14
ID - Indonesia 14
IQ - Iraq 14
ES - Italia 11
JP - Giappone 11
CZ - Repubblica Ceca 10
ZA - Sudafrica 10
FR - Francia 9
CO - Colombia 8
PE - Perù 8
VE - Venezuela 8
EU - Europa 5
PK - Pakistan 5
PY - Paraguay 5
UZ - Uzbekistan 5
BY - Bielorussia 4
EG - Egitto 4
KE - Kenya 4
TN - Tunisia 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
LT - Lituania 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CL - Cile 2
DZ - Algeria 2
ET - Etiopia 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
ML - Mali 1
MW - Malawi 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
UG - Uganda 1
YT - Mayotte 1
Totale 9.759
Città #
Hong Kong 2.844
Ann Arbor 567
Singapore 447
Dallas 325
Woodbridge 317
Chandler 288
Ashburn 223
Princeton 222
Jacksonville 191
Wilmington 167
Houston 148
Dublin 97
Naples 90
Dong Ket 76
Beijing 75
Moscow 50
Los Angeles 49
Ho Chi Minh City 46
Nanjing 41
Izmir 40
Dearborn 39
New York 39
Andover 35
Boardman 35
Pellezzano 33
The Dalles 31
Salerno 30
São Paulo 28
Washington 26
Hanoi 23
Mestre 23
Brooklyn 22
Vienna 20
Munich 19
Santa Clara 19
Nuremberg 18
Denver 17
Amsterdam 16
Düsseldorf 16
Shenyang 16
Stockholm 16
Atlanta 15
Chicago 15
Seattle 15
Warsaw 15
San Francisco 14
Council Bluffs 13
Norwalk 13
Pune 13
Fairfield 12
Montreal 12
Chennai 11
Rio de Janeiro 11
Rome 11
Seoul 11
West Jordan 11
Brno 10
Hebei 10
Jiaxing 10
London 10
Tianjin 10
Tokyo 10
Ankara 9
Mexico City 9
Columbus 8
Johannesburg 8
Nanchang 8
San Diego 8
Curitiba 7
Haiphong 7
Phoenix 7
Poplar 7
Baghdad 6
Biên Hòa 6
Boston 6
Lappeenranta 6
Quito 6
San Jose 6
Arba 5
Brasília 5
Caracas 5
Charlotte 5
Eboli 5
Frankfurt am Main 5
Goiânia 5
Guayaquil 5
Helsinki 5
Manaus 5
Manchester 5
Milan 5
Nola 5
Orem 5
Redwood City 5
Ribeirão Preto 5
Shanghai 5
Tashkent 5
Turku 5
Belo Horizonte 4
Buenos Aires 4
Cairo 4
Totale 7.297
Nome #
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 726
Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study 347
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 343
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 318
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 285
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 242
A systematic review of pediatrics NAFLD therapy: year 2012 219
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 208
Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis 192
Humanization interventions in general pediatric wards: a systematic review 178
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 168
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 160
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 155
Atypical celiac disease presenting as obesity-related liver dysfunction. 144
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 142
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 140
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 132
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 124
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 123
Autoimmune manifestations in pediatric liver transplantation recipients 123
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 123
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 119
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 117
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 109
Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease 108
Cytochrome 2C19: a New Hepatic Target of Immune Reactions After Orthopic Liver Transplantation. 106
More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease 105
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation 103
Frequent persistence of hepatic abnormalities in children with hereditary fructose intolerance (HFI) is not correlated to specific gene mutations. 102
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 101
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions 101
Insulin sensitivity and iron metabolism in pediatric obesity related liver disease. 100
Chronic liver disease in two children exposed to moderately high levels of copper in drinking water. 100
Novel congenital disorders of glycosylation may underlie cryptogenic liver disease in children. 99
Congenital defects of glycosylation may underlie cryptogenic hepatopathy in asymptomatic children 98
A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant 98
Interplay between metabolic, oxidative, inflammatory and hormonal factors in pediatric obesity related liver disease. 97
Chronic ingestion of moderately high copper may cause cryptogenic mild liver disease 96
Per-rectal portal scintigraphy is complementary to ultrasonography and endoscopy in the assessment of portal hypertension in children with chronic cholestasis 95
Oral vitamin E has beneficial effects on liver disease of obese children unable to loose weight 95
Non-cirrhotic chronic liver disease in three italian children exposed to moderately high copper intakes 92
Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature 86
Humanization of pediatric care in the world: focus and review of existing models and measurement tools. 86
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy 86
Human Parvovirus B19 Infection in liver transplanted children with chronic hematologic disorders. 84
More on vitamin E therapy 82
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. 80
Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path 76
Global multi-stakeholder endorsement of the MAFLD definition 69
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review 68
Outbreak of paediatric myocarditis associated with parvovirus B19 infection in Italy, January to October 2024 65
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation 64
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 59
Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene 59
Nutrition and Liver Disease 55
Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review 55
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease 53
Bassa statura non sindromica e ritardo puberale: non solo ritardo costituzionale di crescita e pubertà 52
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era 51
Drug dosing in children with obesity: a narrative updated review 50
Ittero e feci ipocoliche: allarme atresia delle vie biliari 50
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics 48
ALAGILLE SYNDROME: IS IT ALWAYS CHOLESTASIS? 48
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis 47
Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population 47
Real-word experience with Odevixibat in children with Progressive Familial Intrahepatic Cholestasis 47
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 47
Crohn-Like Colitis in a Young Boy with Hirschsprung Disease 46
Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature 45
Laryngeal Mask for Minimally-Invasive Surfactant Administration: A Narrative Review 44
The gut-liver axis as a target of liver disease management 44
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 42
Genetics, epigenetics and transgenerational transmission of obesity in children 42
Systemic Cat-Scratch Disease: a "Troublesome" Diagnosis 42
Cholestatic jaundice in infancy: Struggling with many old and new phenotypes 41
Consumptive Hypothyroidism due to Hepatic Hemangiomas: A Case Series and Review of the Literature 39
Malnutrition in pediatric chronic cholestatic disease: An up-to-date overview 39
A persistent fever associated with elevated inflammatory indices and ultrasound lesions of liver and spleen 39
Letter to the editor in response to distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase 38
Reasons why treatment of metabolic dysfunction‐associated steatotic liver disease may benefit from targeting the gut–liver axis as well 38
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 37
Acute hepatitis of unknown origin in children: Should we move the discussion from a purely infectious origin also to other plausible causes? 37
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection 36
Letter to the Editor in response to: “ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis” 35
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age 35
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 35
An odd septic arthritis of the hip 34
An almost accidentally diagnosis 32
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 31
The complexity of diagnosing a drug reaction syndrome in the child|La complessità della diagnosi di una sindrome da reazione a farmaco nel bambino 31
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 30
Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children 30
Perceptions and Expectations of Youth Regarding the Respect for Their Rights in the Hospital 30
Bronchiolitis: Compliance with guidelines 30
Emerging, re‐emerging and/or atypically behaving infectious diseases 30
Isolated aspartate aminotransferase elevation: Is it liver disease or what else? 28
Evaluation of non organ specific autoantibodies in children transplanted for non-autoimmune liver diseases 27
The C677T mutation of the 5,1O-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy 26
Thrombotic Features as the Primary Cause of SARS-CoV-2 Related Acute Abdomen in Children 26
Nutritional therapy in liver transplantation 26
Totale 9.412
Categoria #
all - tutte 35.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.747


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 0 0 9 33 4 50 7 44 87
2021/2022360 5 0 0 3 6 2 1 10 52 39 51 191
2022/2023721 70 51 54 83 78 158 1 56 120 4 35 11
2023/2024533 29 48 43 25 32 89 41 24 14 43 24 121
2024/20251.193 21 22 19 54 42 190 185 100 184 101 175 100
2025/20264.982 375 1.840 1.514 322 658 273 0 0 0 0 0 0
Totale 9.953